CD274 and cancer: Oh et al. (2021), in a combined analysis of patients with different cancers, reported mean pre-checkpoint therapy plasma PD-L1 levels of 13.5 ± 12.1 pg/μL vs. 10.6 pg/uL in healthy donors.